{"id":"nicotine-4-mg","safety":{"commonSideEffects":[{"rate":null,"effect":"Mouth irritation"},{"rate":null,"effect":"Hiccups"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Jaw soreness"}]},"_chembl":null,"_dailymed":{"setId":"5c394758-1179-455a-a562-c8e954fb2258","title":"HABITROL NICOTINE POLACRILEX 4 MG COATED CINNAMON (NICOTINE POLACRILEX) GUM, CHEWING [DR. REDDY'S LABORATORIES INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nicotine is an alkaloid that acts as an agonist at nicotinic acetylcholine receptors, mimicking the effects of acetylcholine. By delivering controlled doses of nicotine without the harmful combustion products of tobacco, it reduces the withdrawal symptoms and cravings associated with smoking cessation, allowing patients to gradually reduce their dependence on nicotine.","oneSentence":"Nicotine binds to nicotinic acetylcholine receptors in the brain and peripheral nervous system, providing nicotine replacement to reduce cravings and withdrawal symptoms during smoking cessation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:18:36.436Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Smoking cessation aid"}]},"trialDetails":[{"nctId":"NCT06356610","phase":"NA","title":"Pharmacokinetic and Subjective Effects of Heated Tobacco Products","status":"COMPLETED","sponsor":"Altria Client Services LLC","startDate":"2024-02-06","conditions":"Tobacco Use","enrollment":80},{"nctId":"NCT05630781","phase":"NA","title":"Orexin s Role in the Neurobiology of Substance Use Disorder","status":"RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2023-02-15","conditions":"Nicotine Dependence","enrollment":140},{"nctId":"NCT07476144","phase":"PHASE1","title":"Nordic Spirit Pouch Nicotine Pharmacokinetics Abuse Liability","status":"RECRUITING","sponsor":"JT International SA","startDate":"2026-01-08","conditions":"Smoking Behaviors","enrollment":55},{"nctId":"NCT06966362","phase":"PHASE4","title":"Varenicline for Smoking Reduction in Veterans Not Ready To Quit","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-07-01","conditions":"Veterans, Tobacco Use Disorder, Cigarette Smoking","enrollment":400},{"nctId":"NCT06720909","phase":"NA","title":"Mindfulness And Placebo for Pain (MAPP) Study","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-01-27","conditions":"Chronic Pain","enrollment":45},{"nctId":"NCT06584929","phase":"NA","title":"Rural Smoking Cessation","status":"NOT_YET_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2026-05-01","conditions":"Smoking Cessation","enrollment":272},{"nctId":"NCT05452278","phase":"NA","title":"A Relative Bioavailability Study of Nicotine Delivery From Selected Oral Nicotine Products","status":"COMPLETED","sponsor":"Imperial Brands PLC","startDate":"2021-10-21","conditions":"Healthy Volunteers","enrollment":27},{"nctId":"NCT06620276","phase":"NA","title":"ACT_for Alcohol Use Disorder and Depression","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2025-05-01","conditions":"Depression - Major Depressive Disorder, Alcohol Use Disorder","enrollment":30},{"nctId":"NCT04965181","phase":"NA","title":"Mindfulness-based Smoking Cessation Enhanced With Mobile Technology","status":"COMPLETED","sponsor":"Georgia State University","startDate":"2021-07-01","conditions":"Cigarette Smoking","enrollment":504},{"nctId":"NCT07165808","phase":"NA","title":"Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-02-13","conditions":"Nicotine Addiction","enrollment":84},{"nctId":"NCT07099638","phase":"PHASE2","title":"Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation","status":"NOT_YET_RECRUITING","sponsor":"University of Oklahoma","startDate":"2026-03","conditions":"Smoking Cessation","enrollment":496},{"nctId":"NCT04525755","phase":"PHASE1, PHASE2","title":"STARS (Smoking Treatment And Remote Sampling) Study","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2021-02-08","conditions":"Smoking, Smoking Cessation, Tobacco Smoking","enrollment":652},{"nctId":"NCT06173778","phase":"PHASE2","title":"Semaglutide for Post-Smoking Cessation Weight Management","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2024-04-23","conditions":"Obesity, Overweight, Cigarette Smoking","enrollment":197},{"nctId":"NCT03461874","phase":"NA","title":"ACT Therapy for HF Migraine","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2018-03-15","conditions":"Migraine Without Aura","enrollment":64},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT06554873","phase":"PHASE3","title":"Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders","status":"COMPLETED","sponsor":"Rose Research Center, LLC","startDate":"2024-08-29","conditions":"Smoking Cessation, Harm Reduction","enrollment":150},{"nctId":"NCT05587504","phase":"NA","title":"Determination of Liquid Flavor and Nicotine Form Outcomes","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2023-07-21","conditions":"Electronic Cigarettes","enrollment":13},{"nctId":"NCT05205811","phase":"PHASE3","title":"The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette","status":"COMPLETED","sponsor":"Rose Research Center, LLC","startDate":"2021-12-14","conditions":"Smoking Cessation","enrollment":180},{"nctId":"NCT04634071","phase":"PHASE2","title":"Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment","status":"COMPLETED","sponsor":"Joseph Valentino, MD","startDate":"2021-01-12","conditions":"Smoking Cessation, Cancer, Treatment-Related","enrollment":126},{"nctId":"NCT07145866","phase":"PHASE4","title":"Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-15","conditions":"Nicotine Dependence, Transcranial Magnetic Stimulation, Vaping","enrollment":30},{"nctId":"NCT06747871","phase":"NA","title":"Opioids, Low Nicotine Cigarettes, and Chronic Pain","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-04-15","conditions":"Chronic Pain, Tobacco Use, Opioid Substitution Treatment","enrollment":60},{"nctId":"NCT07323511","phase":"NA","title":"Abuse Liability for Eight Electronic Nicotine Products","status":"NOT_YET_RECRUITING","sponsor":"RAI Services Company","startDate":"2026-02-15","conditions":"Smoking, Smoking Behaviors, Tobacco Use","enrollment":70},{"nctId":"NCT07132814","phase":"NA","title":"Abuse Liability for Five Modern Oral Nicotine Products","status":"RECRUITING","sponsor":"RAI Services Company","startDate":"2025-12-15","conditions":"Smoking, Smoking Behaviors, Tobacco Use","enrollment":40},{"nctId":"NCT05703672","phase":"PHASE3","title":"Switching to E-cigarettes in Smokers Not Interested in Quitting","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-07-17","conditions":"Smoking Reduction","enrollment":500},{"nctId":"NCT06777784","phase":"NA","title":"Modern Nicotine Oral Product Abuse Liability","status":"COMPLETED","sponsor":"RAI Services Company","startDate":"2025-02-03","conditions":"Smoking, Tobacco Use","enrollment":40},{"nctId":"NCT07267195","phase":"NA","title":"Abuse Liability for Four Heated Tobacco Product (HTP) Consumables and Two HTP Devices","status":"NOT_YET_RECRUITING","sponsor":"RAI Services Company","startDate":"2026-01","conditions":"Smoking, Smoking Behaviors, Tobacco Use","enrollment":40},{"nctId":"NCT07254832","phase":"NA","title":"Effects of Caffeine and Nicotine Gum on Balance Performance in Athletes","status":"COMPLETED","sponsor":"Gülbin Rudarlı","startDate":"2024-01-08","conditions":"Athletic Performance, Postural Stability, Healhty","enrollment":20},{"nctId":"NCT04033237","phase":"PHASE1, PHASE2","title":"Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2019-08-21","conditions":"Tobacco Use Disorder","enrollment":30},{"nctId":"NCT06474299","phase":"PHASE4","title":"The Avenues Study: Dual Use Cessation","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-09-24","conditions":"Smoking Cessation, Electronic Cigarette Use","enrollment":500},{"nctId":"NCT00494728","phase":"PHASE1, PHASE2","title":"Smoking Cessation for Depressed Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2007-06-28","conditions":"Smoking, Depression","enrollment":91},{"nctId":"NCT07075575","phase":"NA","title":"Quit-Smoking Study for Native Hawaiians","status":"RECRUITING","sponsor":"University of Hawaii","startDate":"2025-11-01","conditions":"Tobacco Use Disorder, Smoking Cessation","enrollment":75},{"nctId":"NCT05362318","phase":"NA","title":"Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2021-06-07","conditions":"Smoking, Tobacco Use, Lung Cancer","enrollment":21},{"nctId":"NCT04234997","phase":"PHASE2","title":"Suvorexant to Reduce Symptoms of Nicotine Use","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-08-23","conditions":"Smoking Cessation","enrollment":14},{"nctId":"NCT04199117","phase":"PHASE4","title":"Health Systems Reach Interventions Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-03-11","conditions":"Smoking, Cigarette, Smoking Cessation","enrollment":210},{"nctId":"NCT05370313","phase":"NA","title":"The Impact of Innovative Tax Proposals on Purchase Patterns","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2023-04-11","conditions":"Cigarette Smoking","enrollment":285},{"nctId":"NCT02032212","phase":"NA","title":"A Bioavailability Study of Nicotine Delivered by an Electronic Vapour Product","status":"COMPLETED","sponsor":"Imperial Brands PLC","startDate":"2013-12","conditions":"Healthy Volunteers","enrollment":12},{"nctId":"NCT06098144","phase":"PHASE4","title":"Smoking Cessation Program in the Construction Sector","status":"RECRUITING","sponsor":"University of Miami","startDate":"2024-04-10","conditions":"Smoking Cessation, Tobacco Use Cessation, Tobacco Smoking","enrollment":608},{"nctId":"NCT05032755","phase":"NA","title":"Low Nicotine Cigarettes, Smoking, and Chronic Pain","status":"COMPLETED","sponsor":"Duke University","startDate":"2022-06-23","conditions":"Chronic Pain, Smoking, Cigarette","enrollment":40},{"nctId":"NCT07095205","phase":"PHASE4","title":"PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.","status":"RECRUITING","sponsor":"Stony Brook University","startDate":"2024-10-03","conditions":"Major Depressive Disorder (MDD)","enrollment":14},{"nctId":"NCT04236791","phase":"NA","title":"The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Bern","startDate":"2018-07-16","conditions":"Smoking Cessation","enrollment":1246},{"nctId":"NCT04188873","phase":"PHASE4","title":"Cessation Screening Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-12-10","conditions":"Nicotine Dependence","enrollment":529},{"nctId":"NCT05396014","phase":"PHASE4","title":"The BEST Trial: Biomarkers for Evaluating Spine Treatments","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-09-12","conditions":"Chronic Low-back Pain","enrollment":1014},{"nctId":"NCT05430334","phase":"NA","title":"Assess the Influence of Nicotine Flux and Nicotine Form on Subjective Effects Related to Dependency","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2022-07-13","conditions":"Nicotine Vaping, Nicotine Dependence, Nicotine Addiction","enrollment":130},{"nctId":"NCT05154669","phase":"PHASE3","title":"Integrating Financial Coaching and Smoking Cessation Coaching","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2022-12-08","conditions":"Smoking","enrollment":488},{"nctId":"NCT05683821","phase":"NA","title":"BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2023-07-24","conditions":"Quitting Smoking, Smoking Cessation, Smoking, Cigarette","enrollment":12376},{"nctId":"NCT06598397","phase":"PHASE4","title":"Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care","status":"RECRUITING","sponsor":"New York University","startDate":"2024-10-18","conditions":"Human Immunodeficiency Virus (HIV), Smoking Cessation","enrollment":500},{"nctId":"NCT06448351","phase":"NA","title":"Manipulating E-Cigarette Nicotine to Promote Public Health","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2024-05-20","conditions":"Tobacco-Related Carcinoma","enrollment":350},{"nctId":"NCT06931054","phase":"NA","title":"Combination of Acupuncture, Auricular Acupressure and Nicotine Replacement Therapy for Smoking Cessation","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-05-05","conditions":"Smoking","enrollment":270},{"nctId":"NCT04969198","phase":"PHASE2","title":"UW Withdraw From Tobacco Study","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2021-07-13","conditions":"Tobacco Dependence","enrollment":232},{"nctId":"NCT00943618","phase":"PHASE3","title":"Combining Varenicline and Bupropion for Smoking Cessation","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-05-17","conditions":"Smoking Cessation","enrollment":641},{"nctId":"NCT05257629","phase":"PHASE3","title":"Aggressive Smoking Cessation Trial (ASAP)","status":"RECRUITING","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2023-02-02","conditions":"Acute Coronary Syndrome, Cardiovascular Diseases","enrollment":798},{"nctId":"NCT05367492","phase":"PHASE4","title":"Varenicline for Nicotine Vaping Cessation in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2022-06-22","conditions":"Vaping, Nicotine Dependence","enrollment":261},{"nctId":"NCT06096714","phase":"EARLY_PHASE1","title":"Addictive Threshold of Nicotine","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-02-27","conditions":"Smoking Addiction","enrollment":36},{"nctId":"NCT06303115","phase":"NA","title":"CSD231005 Nicotine Pouch Biomarkers of Exposure","status":"COMPLETED","sponsor":"RAI Services Company","startDate":"2024-08-22","conditions":"Tobacco Use, Smoking","enrollment":200},{"nctId":"NCT03720899","phase":"PHASE2, PHASE3","title":"Comparing NicoBloc to Nicotine Lozenges","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2019-03-21","conditions":"Smoking Cessation, Nicotine Dependence","enrollment":45},{"nctId":"NCT04725656","phase":"NA","title":"Concentration Impact Nicotine Salt","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-01-30","conditions":"Smoking Cessation, Vaping","enrollment":312},{"nctId":"NCT04332926","phase":"NA","title":"Effects of E-Cigarette Nicotine Content in Smokers (Nicotine Flux Study)","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2021-01-05","conditions":"Electronic Cigarette Use","enrollment":44},{"nctId":"NCT06691386","phase":"NA","title":"Nicotine Pharmacokinetics and Subjective Effects of Oral Nicotine Products Relative to Smokeless Tobacco in Adult Users","status":"COMPLETED","sponsor":"Altria Client Services LLC","startDate":"2023-02-06","conditions":"Tobacco Use","enrollment":64},{"nctId":"NCT05275725","phase":"PHASE1","title":"Finding Solutions to Thrive After Birth Asphyxia in Africa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pia Wintermark","startDate":"2022-07-01","conditions":"Birth Asphyxia","enrollment":18},{"nctId":"NCT04063267","phase":"PHASE2","title":"Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2020-10-27","conditions":"Cigarette Smoking, Addiction, E Cig Use","enrollment":48},{"nctId":"NCT05664672","phase":"NA","title":"Study to Evaluate Changes in Smokers Using on!® Nicotine Pouches","status":"COMPLETED","sponsor":"Altria Client Services LLC","startDate":"2021-05-11","conditions":"Tobacco Use","enrollment":149},{"nctId":"NCT03281694","phase":"PHASE1","title":"The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2018-05","conditions":"Cognitive Change","enrollment":""},{"nctId":"NCT03611881","phase":"PHASE4","title":"Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-04-01","conditions":"Smoking, Tobacco","enrollment":642},{"nctId":"NCT03384784","phase":"PHASE2","title":"Effect of Galantamine on Inflammation and Cognition","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2017-10-30","conditions":"HIV Associated Cognitive Motor Complex","enrollment":63},{"nctId":"NCT05280769","phase":"NA","title":"Effects of an Oral Nicotine Product in Smokeless Tobacco Users","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2022-08-23","conditions":"Tobacco Use","enrollment":31},{"nctId":"NCT05317195","phase":"NA","title":"Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers","status":"COMPLETED","sponsor":"Philip Morris Products S.A.","startDate":"2022-03-15","conditions":"Smoking, Nicotine","enrollment":31},{"nctId":"NCT03557294","phase":"PHASE4","title":"Varenicline OTC Trial on Efficacy and Safety","status":"COMPLETED","sponsor":"Arizona State University","startDate":"2018-05-07","conditions":"Tobacco Dependence, Withdrawal Symptoms, Smoking Cessation","enrollment":313},{"nctId":"NCT06171490","phase":"NA","title":"Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg)","status":"COMPLETED","sponsor":"Philip Morris Products S.A.","startDate":"2023-10-20","conditions":"Tobacco Use","enrollment":56},{"nctId":"NCT04038515","phase":"PHASE2","title":"Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-10-27","conditions":"Nicotine, E-liquid Flavors","enrollment":54},{"nctId":"NCT03538938","phase":"PHASE4","title":"Improving Quitline Support Study","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2018-06-07","conditions":"Tobacco Use Cessation","enrollment":1316},{"nctId":"NCT05181891","phase":"PHASE2","title":"Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking","status":"RECRUITING","sponsor":"Washington State University","startDate":"2022-07-11","conditions":"Alcohol Use Disorder (AUD), Nicotine Use Disorder","enrollment":205},{"nctId":"NCT03169101","phase":"","title":"Cognition and Smoking Relapse (HCS)","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2016-07-01","conditions":"Smoking Cessation","enrollment":274},{"nctId":"NCT04384562","phase":"NA","title":"Studying the Role of Brain Molecules for Decision Making","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2020-12-17","conditions":"Decision Making, Healthy","enrollment":160},{"nctId":"NCT05129657","phase":"NA","title":"CSD201001: Study to Assess Elements of Abuse Liability for Three Nicotine Pouches","status":"COMPLETED","sponsor":"RAI Services Company","startDate":"2021-11-02","conditions":"Smoking, Tobacco Use, Tobacco Smoking","enrollment":40},{"nctId":"NCT04602494","phase":"PHASE4","title":"Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2020-12-18","conditions":"Vaping, Nicotine Dependence","enrollment":5},{"nctId":"NCT06063421","phase":"NA","title":"Comparison of Nicotine Replacement Therapy and Electronic Cigarettes for Smoking Cessation in Pakistan","status":"NOT_YET_RECRUITING","sponsor":"Strategic Health Research Limited","startDate":"2024-06-01","conditions":"Smoking Cessation, Electronic Cigarette Use","enrollment":438},{"nctId":"NCT00727103","phase":"PHASE4","title":"Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia","status":"COMPLETED","sponsor":"State University of New York - Upstate Medical University","startDate":"2008-07","conditions":"Schizophrenia, Schizoaffective Disorder, Alcohol Dependence","enrollment":10},{"nctId":"NCT01589055","phase":"NA","title":"IV Nicotine Induced Changes in Hormone Function, Mood States and Behavior","status":"WITHDRAWN","sponsor":"Mclean Hospital","startDate":"2005-04","conditions":"Nicotine Dependence","enrollment":""},{"nctId":"NCT06170138","phase":"NA","title":"Study to Assess PK, PD, Nicotine Extraction, Palatability, Subjective Effects of Nicotine Pouches - Daily Nicotine Users","status":"UNKNOWN","sponsor":"Amplicon AB","startDate":"2023-11-24","conditions":"Nicotine Use Disorder","enrollment":12},{"nctId":"NCT04286295","phase":"NA","title":"Cytisine Compared to Combination NRT in Relapsed Smokers","status":"TERMINATED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2022-03-14","conditions":"Smoking Cessation, Coronary Artery Disease","enrollment":13},{"nctId":"NCT05157672","phase":"EARLY_PHASE1","title":"Evaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement Cinnamon","status":"UNKNOWN","sponsor":"Washington State University","startDate":"2021-12-14","conditions":"Interaction Drug Food","enrollment":16},{"nctId":"NCT05825924","phase":"PHASE3","title":"Effectiveness of Different THR Products in Adult Population","status":"UNKNOWN","sponsor":"Foundation for a Smoke Free World INC","startDate":"2024-06","conditions":"Smoking Cessation","enrollment":258},{"nctId":"NCT00888459","phase":"PHASE2","title":"A Pilot Study Evaluating Nicotine Lozenges and Self Help","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-04","conditions":"Smokeless Tobacco Use","enrollment":60},{"nctId":"NCT04891406","phase":"NA","title":"A Randomised, Cross-over, Relative Bioavailability Study of Nicotine Delivery and Nicotine Extraction From Oral Products","status":"COMPLETED","sponsor":"Imperial Brands PLC","startDate":"2020-07-01","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT05060965","phase":"EARLY_PHASE1","title":"Inpatient Smoking Cessation Pilot Program","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2019-10-01","conditions":"Tobacco Use Cessation","enrollment":""},{"nctId":"NCT04717544","phase":"NA","title":"Embedding Comprehensive Smoking Cessation Programs Into Community Clinics","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2019-10-01","conditions":"Smoking Cessation","enrollment":406},{"nctId":"NCT02157610","phase":"NA","title":"Smoking Cessation for Cervical Cancer Survivors","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2015-01","conditions":"Cervical Cancer, Tobacco Use, Smoking Cessation","enrollment":202},{"nctId":"NCT04465318","phase":"NA","title":"Electronic Cigarettes as a Harm Reduction Strategy Among Patients With COPD","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2020-11-09","conditions":"COPD","enrollment":146},{"nctId":"NCT04084210","phase":"PHASE2","title":"Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-09-09","conditions":"Nicotine Dependence","enrollment":209},{"nctId":"NCT03897439","phase":"PHASE3","title":"Individualizing Pharmacotherapy for African American Smokers","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2019-05-01","conditions":"Smoking Cessation","enrollment":392},{"nctId":"NCT05484505","phase":"EARLY_PHASE1","title":"Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan","status":"UNKNOWN","sponsor":"Nazarbayev University","startDate":"2023-07-01","conditions":"Smoking Cessation, Smoking, Cigarette, Smoking Behaviors","enrollment":200},{"nctId":"NCT03176784","phase":"PHASE4","title":"UW Quitting Using Intensive Treatment Study (QUITS)","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-11-11","conditions":"Tobacco Dependence","enrollment":1251},{"nctId":"NCT03861078","phase":"NA","title":"The Effect of Electronic Cigarette Liquid Characteristics in Smokers.","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2020-02-17","conditions":"Electronic Cigarettes","enrollment":22},{"nctId":"NCT03473483","phase":"NA","title":"Cigarette Harm Reduction With Electronic Cigarette Use","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2022-08-01","conditions":"Nicotine Dependence, Tobacco Toxicity, Nicotine Dependence, Cigarettes","enrollment":""},{"nctId":"NCT02796391","phase":"PHASE2","title":"Facilitating Smoking Cessation With Reduced Nicotine Cigarettes","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2017-09-07","conditions":"Smoking Cessation","enrollment":163},{"nctId":"NCT03060083","phase":"PHASE2, PHASE3","title":"Switching to Very Low Nicotine Content Cigarettes vs Reducing Cigarettes Per Day","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2017-02-08","conditions":"Tobacco Use Disorder","enrollment":74},{"nctId":"NCT02723162","phase":"PHASE2","title":"Translational Neuropsychopharmacology Research of Nicotine Addiction","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2016-05-04","conditions":"Nicotine Dependence, Cigarettes","enrollment":67},{"nctId":"NCT01954966","phase":"PHASE4","title":"Progesterone and Brain Imaging Study","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-11","conditions":"Nicotine Dependence, Nicotine Withdrawal","enrollment":81},{"nctId":"NCT05210699","phase":"NA","title":"CSD201201: Study to Assess Elements of Abuse Liability for Electronic Nicotine Delivery System P12","status":"COMPLETED","sponsor":"RAI Services Company","startDate":"2022-03-21","conditions":"Smoking, Smoking Behaviors, Tobacco Use","enrollment":36},{"nctId":"NCT05294497","phase":"NA","title":"CSD201301: Study to Assess Elements of Abuse Liability for Four P13 Nicotine Pouches","status":"COMPLETED","sponsor":"RAI Services Company","startDate":"2022-05-01","conditions":"Smoking, Tobacco Use, Tobacco Smoking","enrollment":42}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"CHEST PAIN"},{"count":2,"reaction":"DYSPHAGIA"},{"count":2,"reaction":"DYSPNOEA"},{"count":2,"reaction":"HEART RATE INCREASED"},{"count":2,"reaction":"HYPERSENSITIVITY"},{"count":2,"reaction":"INCORRECT DRUG ADMINISTRATION DURATION"},{"count":2,"reaction":"PHARYNGEAL OEDEMA"},{"count":2,"reaction":"URTICARIA"},{"count":1,"reaction":"ACCIDENTAL OVERDOSE"},{"count":1,"reaction":"ARRHYTHMIA"}],"_approvalHistory":[],"publicationCount":35,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Nicotine (4 mg)","genericName":"Nicotine (4 mg)","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nicotine (4 mg) is a small molecule used in various interventions for conditions such as smoking cessation, ADHD, and tobacco use disorder, including self-help materials, nicotine patches, and smartphone-delivered automated treatment. It has been studied in clinical trials for its potential to aid in smoking cessation and management of other conditions.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}